Bottom line
Is VHCIX a good fund? The bottom line
VHCIX is the Admiral share class of Vanguard Health Care Index Fund, an index health care sector mutual fund from Vanguard.
It charges 0.09% — about $9 a year on every $10,000 invested, cheaper than 97% of health care sector funds we track.
It returned +2.7% over one year, +7.2% a year over five years, +8.8% a year over ten (as of Dec 31, 2024, per its prospectus).
With $19.0 billion in net assets and 407 holdings, its largest position is Eli Lilly & Co (14.0%) and the top 10 make up 51.9% of the portfolio.
The closest lower-cost alternative we found is XLV (0.08%, 94% top-holdings overlap).
What stands out
- Low cost: cheaper than 97% of health care sector peers
- 5-year return beat 88% of category peers
- Broadly diversified (407 holdings)
- No front-end sales load
- Large and established ($19.0 billion)
What to watch
- Concentrated: top 10 holdings are 51.9% of assets
Updated Nov 19, 2026
What VHCIX invests in
Vanguard Health Care ETF, an exchange-traded share class of Vanguard Health Care Index Fund (the Fund), seeks to track the performance of a benchmark index that measures the investment return of health care stocks.
The Fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50 (the Target Index), an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The GICS health care sector includes health care provider and services companies, companies that manufacture and distribute health care equipment and supplies, and health care technology companies. It also includes companies involved in the research, development, production, and marketing of pharmaceuticals and biotechnology products. Under normal circumstances, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks that make up the Target Index. The Fund attempts to replicate the…
From the fund's prospectus (filed Jun 30, 2026).
VHCIX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| VHCIX | +2.7% | +7.2% | +8.8% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2024
What VHCIX costs
On a $10,000 investment, VHCIX's 0.09% expense ratio costs about $9 a year. The prospectus estimates $115 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
VHCIX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Co | 14.04% |
| 2 | Johnson & Johnson | 8.47% |
| 3 | AbbVie Inc | 6.09% |
| 4 | UnitedHealth Group Inc | 5.45% |
| 5 | Merck & Co Inc | 4.66% |
| 6 | Thermo Fisher Scientific Inc | 2.93% |
| 7 | Amgen Inc | 2.87% |
| 8 | Gilead Sciences Inc | 2.64% |
| 9 | Intuitive Surgical Inc | 2.38% |
| 10 | Pfizer Inc | 2.35% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 51.9% of the fund. See all top 25 holdings and asset mix →
Alternatives to VHCIX
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| SPDR (State Street) | XLV State Street(R) Health Care Select… | 0.08% | 94% | Compare |
| Fidelity | FHLC Fidelity MSCI Health Care Index ETF | 0.084% | 94% | Compare |
| iShares | IYH iShares U.S. Healthcare ETF | 0.37% | 92% | Compare |
| J.P. Morgan | JDOC JPMorgan Healthcare Leaders ETF | 0.65% | 61% | Compare |
| Schwab | SWHFX Schwab Health Care Fund | 0.8% | 75% | Compare |
| T. Rowe Price | QAAGZX T. Rowe Price Health Sciences Portfolio | 0.86% | 79% | Compare |